We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"... Retevmo delivered positive topline outcomes in early stage lung cancer in the latest study readout. Eli Lilly is a large global pharmaceutical ..."
"The phase 3 LIBRETTO-432 trial of Retevmo (selpercatinib) as adjuvant therapy delivered a "highly statistically significant and clinically ..."
"Hello all! I was diagnosed with thyroid medullary cancer last year. I've had my entire thyroid removed since then and seem to be doing pretty well ..."
"... Gavreto and Rezlidhia, provide support to RIGL's top-line momentum. Based on the unaudited numbers, full-year 2025 product sales are expected to ..."
"OncoDaily (@oncodaily). 21 views. EFS with Adjuvant Selpercatinib in Early-Stage RET FusionPositive NSCLC - Shaheenah Dawood @Shaheenah1 ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.